Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Short term Debt (2024 - 2025)

Arcutis Biotherapeutics (ARQT) has 2 years of Short term Debt data on record, last reported at $1.0 million in Q4 2025.

  • For Q4 2025, Short term Debt changed N/A year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.0 million, changed N/A, while the annual FY2025 figure was $1.0 million, N/A changed from the prior year.
  • Short term Debt reached $1.0 million in Q4 2025 per ARQT's latest filing, roughly flat from $1.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $99.5 million in Q3 2024 and bottomed at $1.0 million in Q2 2025.